← All Biostax CORP filings

Biostax CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
BTAX
Biostax CORP
10-K/A: Biostax Corp Files Amended 10-K After Identifying Accounting Errors
Biostax Corp has filed an amended 10-K to correct errors in intangible assets, notes payable, and related party liabilities, and to include previously missing exhibits.
OTC.Pink
BTAX
Biostax CORP
10-K: Biostax Corp Files 10-K, Outlines Strategy for Growth in Pharmaceutical and Biotech Sectors
Biostax Corp's 2023 10-K filing details its strategic focus on acquiring, developing, and commercializing pharmaceutical and biotechnology products, leveraging a hub-and-spoke model.